GENEVA, July 9 -- DUALITY BIOLOGICS (SUZHOU) CO., LTD. filed a patent application (CN2025/147191) for “PHARMACEUTICAL COMBINATION OF ANTI-HER3 ANTIBODY-DRUG CONJUGATE AND ANTI-HER2 ANTIBODY, AND USE THEREOF”. With publication no. WO/2026/145526, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....